Who is sponsoring NCT06008340?

NCT06008340 is sponsored by Kafrelsheikh University.

What drugs are being tested in NCT06008340?

Interventions in NCT06008340: Dual chamber Pacemaker.

What condition does NCT06008340 study?

NCT06008340 studies Pacing-Induced Cardiomyopathy.

Is NCT06008340 still recruiting?

NCT06008340 is currently status unknown. Last updated 23 August 2023.

Last reviewed 2023-08-23 · How we verify

NCT06008340

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Right Ventricle Lead Position on The Psychological Aspects of Patients With A Dual Chamber Pacemaker

Status unknown Last updated 23 August 2023

What this trial tests

trial testing Dual chamber Pacemaker in Pacing-Induced Cardiomyopathy in 182 participants. Status unknown.

Timeline

1 August 2022

Primary endpoint
1 September 2023

1 November 2023

Quick facts

Lead sponsor	Kafrelsheikh University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	182
Start date	1 August 2022
Primary completion	1 September 2023
Estimated completion	1 November 2023
Sites	1 location across Egypt

Drugs / interventions tested

Dual chamber Pacemaker

Conditions studied

Pacing-Induced Cardiomyopathy — all drugs for Pacing-Induced Cardiomyopathy →

Sponsor

Kafrelsheikh University

Who can join

18 and older, any sex, with Pacing-Induced Cardiomyopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the current study was to determine the factors associated with increased levels of anxiety and depression both before and after pacemaker implantation and examine if changes in these symptoms occur during the first postoperative year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pacing-Induced Cardiomyopathy

Currently open trials in the same condition.

NCT06052475 — Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades · NA · recruiting
NCT05650658 — Left vs Left Randomized Clinical Trial · NA · recruiting
NCT04595487 — LVSP vs RVP in Patients With AV Conduction Disorders · NA · recruiting
NCT04416958 — Pacing to Maintain Physiologic Ventricular Activation · recruiting

Other Kafrelsheikh University trials

Trials by the same sponsor.

NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
NCT07433920 — L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation · NA · recruiting
NCT07368348 — Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cere · NA · recruiting
NCT07348094 — Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin · NA · recruiting
NCT07359144 — Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06008340 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kafrelsheikh University
Last refreshed: 23 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06008340.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing